#USA #Indianapolis #Remote Monitoring #Prevounce Health #Pylo 900-LTE

Prevounce Health Unveils Pylo 900-LTE Blood Pressure Monitor

In an important stride for maternal health, Prevounce Health has launched the Pylo 900-LTE blood pressure monitor, clinically validated and FDA cleared for use during pregnancy. This innovative device is specifically designed for remote patient monitoring, aiding in the management of gestational hypertension, a critical condition affecting a significant number of expectant mothers.

Addressing Maternal Health Needs

Hypertensive disorders during pregnancy (HDP) are among the leading causes of both fetal and maternal morbidity and mortality. Recent data from the CDC indicates that these conditions account for a substantial percentage of maternal deaths during hospital delivery. With this in mind, effective monitoring and management are crucial.

The Pylo 900-LTE is an advancement in remote patient monitoring (RPM) technology, enabling healthcare providers to oversee pregnant patients’ blood pressure levels effectively. By facilitating early detection of hypertension and related complications, this device holds the potential to significantly reduce the risks associated with preeclampsia and eclampsia, particularly in late pregnancy.

Enhanced Monitoring Capabilities

Prevounce Health’s innovative device enables healthcare providers to monitor patients remotely, which can lead to better management of blood pressure and overall maternal health. Along with the Pylo 900-LTE, Prevounce offers comprehensive solutions, including the Pylo GL1-LTE blood glucometer and a full suite of care management services that ensure a holistic approach to maternity care.

Cost-Effective Solutions

The implications of hypertension during pregnancy extend beyond health risks; they also impose significant financial burdens on the healthcare system. A study conducted in California reported that the median cost related to premature births could reach nearly $300,000 per patient. By utilizing effective RPM strategies, Prevounce Health aims to mitigate these costs through early intervention and better health outcomes.

Support from Policymakers

The way maternal health is prioritized is evolving, with increasing attention from policymakers, including the Centers for Medicare & Medicaid Services (CMS). The data-driven approach presented by Prevounce through the Pylo 900-LTE demonstrates not only a commitment to improving health outcomes but also an opportunity for policymakers to invest in more effective healthcare solutions for mothers and their babies.

As the founder and CEO of Prevounce, Daniel Tashnek states, "Clinicians and patients need new tools in the fight against fetal and maternal mortality. We believe that the functionalities offered by our updated remote blood pressure monitor will bolster efforts towards healthier pregnancies." This sentiment underscores the critical need for innovation in the realm of maternal health, echoing the call for new tools and methodologies that can significantly enhance patient care.

Introduction to the Prevounce Platform

The Pylo 900-LTE is part of a broader array of RPM devices developed by Prevounce Health. These devices, which include blood pressure monitors, weight scales, blood glucose meters, and pulse oximeters, are engineered to seamlessly integrate with the Prevounce remote care management platform. Additionally, they offer 5G/4G-LTE connectivity, ensuring real-time data sharing with healthcare providers and fostering a proactive approach to patient health management.

To learn more about the revolutionary Pylo 900-LTE and explore other offerings by Prevounce, visit their official website for in-depth information about their comprehensive maternal health solutions. Through this commitment to patient-centric care, Prevounce Health is paving the way for innovative healthcare practices that prioritize the well-being of mothers and their newborns.